Save 20% on All Global Market Reports With Code ONLINE20 – Gain Insights Into Tariffs, Inflation, and Industry Trends
What Are the Key Factors Driving Benchtop Bioreactors Market Size and Growth?
The benchtop bioreactors market size has grown rapidly in recent years. It will grow from $0.98 billion in 2024 to $1.08 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising focus on cell-based research, rise in academic and research institute funding, increasing interest in tissue engineering, rising use of microbial fermentation processes, and rising adoption in pilot-scale biomanufacturing.
The benchtop bioreactors market size is expected to see rapid growth in the next few years. It will grow to $1.59 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to growing demand for personalized medicine, the rise of biotechnology startups, rising government investments in biotech infrastructure, increasing adoption of single-use bioreactor systems, and the growth of contract research and manufacturing organizations. Major trends in the forecast period include advancement in sensor and monitoring technologies, advanced process control and automation features, innovation in single-use bioreactor designs, integration of artificial intelligence and machine learning in bioprocessing, and advancement in miniaturized bioprocess systems.
Claim your free report sample now:
What Are the Key Factors Contributing to Benchtop Bioreactors Market Growth?
The rising adoption of gene therapies is expected to propel the growth of the benchtop bioreactors market going forward. Gene therapy refers to a medical technique that involves modifying or replacing defective genes to treat or prevent diseases. The increasing demand for gene therapy is due to advancements in genetic sequencing and diagnostics, which enable precise identification of disease-causing genes for targeted treatment. Benchtop bioreactors accelerate gene therapies by enabling precise control and efficient production of gene-modified cells. They support rapid research and small-scale manufacturing, improving process speed and consistency. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the rising adoption of gene therapies is driving the growth of the benchtop bioreactors market.
Which Segment Holds the Largest Share in the Benchtop Bioreactors Market?
The benchtop bioreactors market covered in this report is segmented
1) By Type: Swing-Style Bioreactors, Stirred-Tank Bioreactors, Wave-Mixed Bioreactors, Airlift Bioreactors, Bubble Column Bioreactors
2) By Control Type: Automated Bioreactors, Manual Bioreactors, Continuous Bioreactors, Batch Bioreactors
3) By Material: Stainless Steel, Glass, Plastic, Composite Materials
4) By Application: Research And Development, Process Development, Bioproduction, Quality Control, Training And Education
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs), Food And Beverage Industry
Subsegments:
1) By Swing-Style Bioreactors: Single-Use Swing Bioreactors, Multi-Use Swing Bioreactors, Compact Swing Bioreactors, Automated Swing Bioreactors
2) By Stirred-Tank Bioreactors: Single-Use Stirred-Tank Bioreactors, Glass Stirred-Tank Bioreactors, Stainless-Steel Stirred-Tank Bioreactors, Modular Stirred-Tank Bioreactors, Automated Stirred-Tank Bioreactors
3) By Wave-Mixed Bioreactors: Single-Use Wave-Mixed Bioreactors, Dual-Motion Wave-Mixed Bioreactors, Automated Wave-Mixed Bioreactors, Compact Wave-Mixed Bioreactors
4) By Airlift Bioreactors: Internal Loop Airlift Bioreactors, External Loop Airlift Bioreactors, Single-Use Airlift Bioreactors, Pilot-Scale Airlift Bioreactors
5) By Bubble Column Bioreactors: Vertical Bubble Column Bioreactors, Single-Use Bubble Column Bioreactors, Gas-Lift Bubble Column Bioreactors, Automated Bubble Column Bioreactors
What Are the Notable Trends in the Benchtop Bioreactors Market by Product, Application, and Region?
Major companies operating in the benchtop bioreactors market are focusing on developing innovative solutions, such as benchtop fermenters, to enhance precise control and scalability for research and small-scale production. Benchtop fermenters are compact, laboratory-scale bioreactors designed for controlled cultivation of microorganisms or cells to support research and small-scale production. For instance, in September 2024, VFL Sciences Private Limited, an India-based biotechnology equipment manufacturer, launched the GreatFlo range of benchtop fermenters or bioreactors. This versatile and modular product line is engineered for easy scale-up and consistent reproducibility in fermentation and cell culture applications. These fermenters support seamless parallel operation with flexible expansion options from 2 to 16 vessels, each offering a working volume of 200-500 ml. It is equipped with Peltier-controlled heating and cooling, exhaust condensers, and software compliant with 21 CFR Part 11 and provides precise regulation of agitation, pH, dissolved oxygen, and individual gas mixing.
Who Are the Emerging Players in the Benchtop Bioreactors Market?
Major companies operating in the benchtop bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Sartorius AG, Eppendorf AG, Solaris Biotech Solutions, IKA-Werke GmbH And Co. KG, GPC Bio USA, Praj HiPurity Systems Limited., PBS Biotech Inc., Bioengineering AG, Broadley-James Ltd., Infors HT, Solida Biotech, Bbi-biotech GmbH, Applikon Biotechnology B.V., Labfirst Scientific Instruments Co. Ltd, Pharsol Ltd., Uma Pharmatech Machinery.
Get the full benchtop bioreactors market report here:
What Are the Regional Opportunities for Investment in the Benchtop Bioreactors Market?
North America was the largest region in the benchtop bioreactors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the benchtop bioreactors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
Comments
Post a Comment